The report also reveals that over 130,000 patients (42%) will have a 5-year relative survival greater than 80%.
According to the INCa report, cancers of the prostate, breast, thyroid, testes, lips, Hodgkin’s disease, melanoma and leukemia are cancers with a good prognosis (i.e. 42% of cases of cancers) for which the 5-year survival rate is greater than or equal to 80%.
Among cancers with a poor prognosis whose 5-year survival is less than or equal to 20%, i.e. 17% of cancer cases, the report mentions cancers of the lung, pleura, liver, pancreas and esophagus. and the central nervous system.
Intermediate prognosis cancers with an estimated 5-year survival rate of between 20 and 80% are cancers of the colon, rectum, mouth, pharynx, bladder, kidney, stomach, cervix. uterus, ovary, larynx or acute leukemia.
The report reveals that the 5-year survival for all cancer sites combined is estimated at a rate varying from 51.9 to 67.8% depending on the data sources collected by INCa. Thus, some 165,000 patients could survive, each year, up to 5 years after the diagnosis made by health professionals.
“The survival of patients with cancer is improving, in particular thanks to earlier diagnoses and more effective treatments. (…) Some cancers are curing more and more; some have a poor prognosis; and finally others are evolving. long-term, such as chronic illnesses, ”the report’s authors point out.
